Form 4: Crinetics Pharmaceuticals Executive Receives Stock Options and Restricted Stock Units

Dana Pizzuti, Chief Medical and Development Officer of Crinetics Pharmaceuticals, acquired stock options and restricted stock units on February 20, 2025.

Summary

• Dana Pizzuti, Chief Medical and Development Officer at Crinetics Pharmaceuticals, reported changes in beneficial ownership on February 24, 2025.
• On February 20, 2025, Pizzuti acquired 43,000 shares of common stock through restricted stock units and 65,000 stock options.
• The restricted stock units vest 25% annually starting March 15, 2026.
• The stock options vest in 48 equal monthly installments from February 20, 2025, and have an exercise price of $36.86, expiring on February 19, 2035.
• Following these transactions, Pizzuti directly owns 74,748 shares of common stock and 65,000 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and restricted stock units to a key executive is a standard practice and generally viewed favorably as it aligns management's interests with shareholders.

Positives

• The grant of stock options and restricted stock units to a key executive like Dana Pizzuti aligns her interests with those of the shareholders.
• The vesting schedules for both the restricted stock units and stock options incentivize long-term performance and commitment to Crinetics Pharmaceuticals.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the pharmaceutical industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice in the pharmaceutical industry.
• Companies like Amgen, Gilead Sciences, and Vertex Pharmaceuticals also utilize similar compensation strategies to incentivize their executives.
• The vesting schedules and exercise prices are generally aligned with industry norms to promote long-term value creation.

Stakeholder Impact

• Shareholders may view the granting of stock options and restricted stock units positively as it incentivizes management to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates